Diabetes: GLP-1s might shield lungs from long COVID damage
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Research suggests that certain diabetes medications, known as GLP-1s, may have a protective effect on the lungs in relation to long covid damage. However, other reports indicate that some diabetes treatments may be associated with an increased risk of rare optic nerve damage. The relationship between diabetes and potential protective or harmful effects of related medications remains a subject of ongoing study.